Literature DB >> 3265659

Synthesis of type II collagen is decreased in cartilage cultured with interleukin 1 while the rate of intracellular degradation remains unchanged.

J A Tyler1, H P Benton.   

Abstract

The effect of interleukin 1 (IL1) on the synthesis and degradation of collagen was examined in explants of cultured cartilage. IL1 induced a reversible, dose-dependent (10-100 pM) inhibition of type II collagen synthesis. The proportion of collagen produced decreased selectively from 7% to 1.2% of total protein after 72 h exposure to IL1 (100pM). There was no change in the rate of degradation of newly synthesized collagen. Analysis of newly synthesized material showed that the type II collagen synthesized in the presence of IL1 had the same characteristics as that extracted from unstimulated cartilage. The relative amounts of type II procollagen mRNA were estimated by Northern blot hybridization. The levels were decreased in cartilage cultured with IL1 to a similar extent as that seen for the type II collagen protein. Exposure to IL1 (10-350pM) for 3 days did not induce increased resorption of extracellular collagen in the cultured explants. These data demonstrate that decreased collagen production in cartilage exposed to IL1 is due primarily to decreased amounts of type II procollagen mRNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265659     DOI: 10.1016/s0174-173x(88)80013-x

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  9 in total

1.  Effect of IL-1beta-induced macromolecular depletion on residual quadrupolar interaction in articular cartilage.

Authors:  Arijitt Borthakur; Erik M Shapiro; Jennifer Beers; Sagar Kudchodkar; J Bruce Kneeland; Ravinder Reddy
Journal:  J Magn Reson Imaging       Date:  2002-03       Impact factor: 4.813

2.  Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.

Authors:  R C Billinghurst; L Dahlberg; M Ionescu; A Reiner; R Bourne; C Rorabeck; P Mitchell; J Hambor; O Diekmann; H Tschesche; J Chen; H Van Wart; A R Poole
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

3.  Composition-function relationships during IL-1-induced cartilage degradation and recovery.

Authors:  A W Palmer; C G Wilson; E J Baum; M E Levenston
Journal:  Osteoarthritis Cartilage       Date:  2009-03-03       Impact factor: 6.576

4.  Evidence for altered synthesis of type II collagen in patients with osteoarthritis.

Authors:  F Nelson; L Dahlberg; S Laverty; A Reiner; I Pidoux; M Ionescu; G L Fraser; E Brooks; M Tanzer; L C Rosenberg; P Dieppe; A Robin Poole
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

5.  Identification of a novel inflammatory stimulant of chondrocytes. Early events in cell activation by bradykinin receptors on pig articular chondrocytes.

Authors:  H P Benton; T R Jackson; M R Hanley
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

6.  Transcriptional modulation of cartilage-specific collagen gene expression by interferon gamma and tumour necrosis factor alpha in cultured human chondrocytes.

Authors:  A M Reginato; C Sanz-Rodriguez; A Diaz; R M Dharmavaram; S A Jimenez
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes.

Authors:  M B Goldring; J R Birkhead; L F Suen; R Yamin; S Mizuno; J Glowacki; J L Arbiser; J F Apperley
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.

Authors:  A R Poole; M Ionescu; A Swan; P A Dieppe
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

9.  An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model.

Authors:  Lisa Macrory; Anne Vaughan-Thomas; Peter D Clegg; John F Innes
Journal:  BMC Vet Res       Date:  2009-07-22       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.